31 – 40 of 64
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Immunization with syngeneic interferon-gamma (IFN-g) secreting tumour cells enhance the Therapeutic effect and Abscopal effect from combined treatment of subcutaneously implanted contra-lateral N29 tumours on Fischer rats with Pulsed electric fields (PEF) and 60Co-gamma radiation.
(
- Contribution to journal › Article
-
Mark
Integrated Chromosome 19 Transcriptomic and Proteomic Datasets Derived from Six Glioma-Derived Cancer Stem Cell Lines
(
- Contribution to journal › Article
- 2013
-
Mark
Combined chemotherapy and immunotherapy against experimental malignant brain tumors
(
- Thesis › Doctoral thesis (compilation)
- 2012
-
Mark
Rat Multipotent Mesenchymal Stromal Cells Lack Long-Distance Tropism to 3 Different Rat Glioma Models
(
- Contribution to journal › Article
-
Mark
Treatment of tumour cell with 5-aza-2-deoxycytidine (DAC) for immune tumour therapy of Glioma in Fischer-344 rats
(
- Contribution to journal › Article
- 2011
-
Mark
Human immunoglobulin G levels of viruses and associated glioma risk
(
- Contribution to journal › Article
-
Mark
Prospective analysis of parametric response map-derived MRI biomarkers: : identification of early and distinct glioma response patterns not predicted by standard radiographic assessment
(
- Contribution to journal › Article
- 2010
-
Mark
Synergistic effects of mesenchymal stromal cells and immunotherapy in experimental brain tumors
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Overexpression of ST6GalNAcV, a ganglioside-specific alpha2,6-sialyltransferase, inhibits glioma growth in vivo
2010) In Proceedings of the National Academy of Sciences of the United States of America 107(28). p.51-12646(
- Contribution to journal › Article
-
Mark
Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, irinotecan
(
- Contribution to journal › Article